Key Statistics

Live data from ClinicalTrials.gov showing all actively recruiting mesothelioma trials.

Active Recruiting Trials

Total mesothelioma trials currently recruiting patients

93 recruiting trials ClinicalTrials.gov, January 2026 Source: ClinicalTrials.gov
Data from MesoWatch. Free to use with attribution.

U.S. Trials

Trials available in the United States

52 trials in the U.S. 56% of all recruiting trials Source: ClinicalTrials.gov
Data from MesoWatch. Free to use with attribution.

Immunotherapy Trials

Trials testing immunotherapy approaches

32 immunotherapy trials Leading category in research Source: ClinicalTrials.gov
Data from MesoWatch. Free to use with attribution.

CAR-T Trials

CAR-T cell therapy trials for mesothelioma

5 CAR-T trials Emerging treatment frontier Source: ClinicalTrials.gov
Data from MesoWatch. Free to use with attribution.

Trials by Treatment Category

Breakdown of what types of treatments are being tested in mesothelioma clinical trials.

Trials by Treatment Type

Distribution of active trials by treatment category

Trials by Treatment Category 93 total recruiting trials Immunotherapy: 34% Chemotherapy: 16% Surgery: 9% Targeted: 6% CAR-T: 5% Other: 29% 93 total Immunotherapy 34% (32) Chemotherapy 16% (15) Surgery 9% (8) Targeted 6% (6) CAR-T 5% (5) Other 29% (27) Source: ClinicalTrials.gov
Data from MesoWatch. Free to use with attribution.

Trials by Phase

Clinical trial phases indicate how far along a treatment is in the development process. Phase 3 trials are closest to FDA approval.

Trials by Phase

Distribution of trials by development stage

Active Trials by Phase Phase 3 trials lead to FDA approval Phase 1 23 trials Phase 1/2 15 trials Phase 2 19 trials Phase 3 2 trials Source: ClinicalTrials.gov
Data from MesoWatch. Free to use with attribution.

Top States for Trial Access

States with the most mesothelioma clinical trial sites. Larger states and those with major cancer centers have more options.

Top 10 States by Trial Sites

U.S. states with the most mesothelioma trial locations

Top 10 States by Trial Sites Where patients have the most trial options Texas 42 sites Nevada 42 sites Illinois 36 sites California 33 sites New York 32 sites Washington 31 sites Florida 24 sites Minnesota 23 sites New Jersey 20 sites Massachusetts 17 sites Source: ClinicalTrials.gov
Data from MesoWatch. Free to use with attribution.

Global Distribution

Mesothelioma research is a global effort. The U.S. leads, but significant research is happening in China, Europe, and beyond.

Trials by Country

Global distribution of mesothelioma clinical trials

Trials by Country 93 trials across 25+ countries United States: 48% China: 13% United Kingdom: 8% Italy: 8% France: 7% Other: 16% 109 total United States 48% (52) China 13% (14) United Kingdom 8% (9) Italy 8% (9) France 7% (8) Other 16% (17) Source: ClinicalTrials.gov
Data from MesoWatch. Free to use with attribution.

How to Use These Visualizations

Embed on Your Website

Click "Copy Embed Code" to get an iframe snippet. Attribution to MesoWatch is included.

Download for Presentations

Download SVG or PNG versions. SVG preserves quality at any size.

Share on Social Media

PNG downloads are optimized for social sharing.

Attribution

Free to use with attribution. Link back to mesowatch.org when sharing.

Data Source

All clinical trial data is sourced directly from the official U.S. government clinical trials registry.

Data is refreshed daily. Last update: January 27, 2026